EFFECT OF CLONAZEPAM ON CANNABIS WITHDRAWAL AND RELAPSE IN TREATMENT-SEEKING PATIENTS: COMBINED INPATIENT/OUTPATIENT STUDY
Sponsor: |
National Institute on Drug Abuse |
Enrolling: |
Male and Female Patients |
Study Length: |
13 Weeks |
Clinic Visits: |
30 |
IRB Number: |
7343 |
U.S. Govt. ID: |
NCT02913924 |
Contact: |
Daniel Brooks: 212-923-3031 / brooksd@nyspi.columbia.edu |
The study will have half of the participants randomly assigned to receive placebo (a sugar pill) and the other half will receive clonazepam medication. For the first 5 nights participants will stay inpatient at the New York State Psychiatric Institute Inpatient unit. Then they will be discharged and continue to receive medication or placebo for the 12 weeks of the outpatient part of the study. For these outpatient 12 weeks they will come to the clinic 2 times per week.
This study is closed
Investigator
John Mariani, MD
Are you currently using marijuana? |
Yes |
No |
Have you used marijuana at least 20 days in the past month? |
Yes |
No |
Are you between the ages of 18 and 65? |
Yes |
No |
Can you stay inpatient for 5 nights? |
Yes |
No |